Medicine House — Insulin Exporter Profile
Indian Pharmaceutical Exporter · #11 for Insulin · $571.4K export value · DGFT Verified
Medicine House is the #11 Indian exporter of Insulin with $571.4K in export value and 17 verified shipments. Medicine House holds a 0.8% market share in Insulin exports across 2 countries. The company exports 3 pharmaceutical products worth $634.5K across 3 therapeutic categories.
Medicine House — Insulin Export Profile: Buyers & Destinations
Where Does Medicine House Export Insulin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $449.3K | 14 | 83.6% |
| SAUDI ARABIA | $88.4K | 3 | 16.4% |
Medicine House exports Insulin to 2 countries. The largest destination is UNITED STATES accounting for 83.6% of Medicine House's Insulin shipments. These destinations reflect Medicine House's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Insulin from Medicine House?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| THE IMPORT MANAGER | UNITED STATES | $449.3K | 14 |
| SPECTROPHARMA | SAUDI ARABIA | $88.4K | 3 |
Medicine House supplies Insulin to 2 buyers globally. The largest buyer is THE IMPORT MANAGER (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Insulin Export Value and How Much Does Medicine House Contribute?
India exported $52.4M worth of Insulin through 2,532 shipments from 188 suppliers to 111 countries, serving 384 buyers globally. Medicine House contributes $571.4K to this total, accounting for 0.8% of India's Insulin exports. Medicine House ships Insulin to 2 countries through 2 buyers.
What Is the Average Shipment Value for Medicine House's Insulin Exports?
Medicine House's average Insulin shipment value is $33.6K per consignment, based on 17 shipments totaling $571.4K. The largest destination is UNITED STATES (83.6% of Medicine House's Insulin exports).
How Does Medicine House Compare to Other Indian Insulin Exporters?
Medicine House ranks #11 among 188 Indian Insulin exporters with a 0.8% market share. The top 3 exporters are WOCKHARDT LIMITED ($22.7M), M. J. BIOPHARM PRIVATE LIMITED ($15.2M), GLAND PHARMA LTD ($4.0M). Medicine House processed 17 shipments to 2 destination countries.
What Insulin Formulations Does Medicine House Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICALS FOR HUMAN USE ONLYNON HAZARDOUS NON RESTRICTED ITEMS ONLYINSULIN LISPRO BIPHASIC INJECTION I.P | $272.8K | 8 |
| PHARMACEUTICALS FOR HUMAN USE ONLYNON HAZARDOUS NON RESTRICTED ITEMS ONLYINSULIN LISPRO BIPHASIC INJECTION | $176.6K | 6 |
| PHARMACEUTICALS FOR HUMAN USE ONLYNON HAZARDOUS NON RESTRICTED ITEMS ONLYINSULIN LISPRO I.P (R-DNA ORIGION) | $88.3K | 3 |
Medicine House exports 3 distinct Insulin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICALS FOR HUMAN USE ONLYNON HAZARDOUS NON RESTRICT with 8 shipments worth $272.8K.
Regulatory Requirements: Exporting Insulin to Key Markets
What Medicine House must comply with to export Insulin to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Medicine House Compare to Nearest Insulin Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | TIMES MEDICAMENT PRIVATE LIMITED | $913.8K | 20 | 1 | $45.7K |
| 10 | SANOFI INDIA LIMITED | $640.4K | 16 | 2 | $40.0K |
| 11 | MEDICINE HOUSE ★ | $571.4K | 17 | 2 | $33.6K |
| 8 | ORBIT LIFESCIENCE PRIVATE LIMITED | $450.0K | 9 | 1 | $50.0K |
| 13 | GLAND PHARMA LIMITED | $419.2K | 11 | 5 | $38.1K |
Medicine House ranks #11 among 188 Indian Insulin exporters. Average shipment value of $33.6K compared to the market average of $278.5K. The closest competitors by value are TIMES MEDICAMENT PRIVATE LIMITED and SANOFI INDIA LIMITED.
Which Indian Ports Ship Insulin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 704 | 27.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 646 | 25.5% |
| Bombay Air | 177 | 7.0% |
| Bombay Air Cargo | 123 | 4.9% |
| NHAVA SHEVA SEA (INNSA1) | 108 | 4.3% |
| DELHI AIR | 76 | 3.0% |
| BANGALORE ACC (INBLR4) | 69 | 2.7% |
| JNPT | 68 | 2.7% |
About Medicine House
Medicine House exports 3 products worth $634.5K. Beyond Insulin, top products include Ustekinumab, Daunorubicin. View the complete Medicine House profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Insulin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Insulin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medicine House matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 17 individual customs records matching Medicine House exporting Insulin, covering 3 formulations to 2 countries via 2 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 111+ countries, 384+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Insulin Export Data from Medicine House
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medicine House's Insulin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medicine House
Full Company Profile →
3 products · $634.5K total trade · 3 categories
Insulin Stats
Company Overview
Top Products by Medicine House
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medicine House.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Insulin. For current shipment-level data, contact TransData Nexus.